NEWS #Machine Learning
Why the FDA's Latest Draft Guidance on AI/ML Tools Should Have Startups on High Aler
Explore the implications of the FDA's latest draft guidance on AI/ML tools, delving into its potential impact on innovative startups navigating the evolving regulatory landscape. This blog provides insights into the guidance's key aspects and offers strategic considerations for businesses in the health tech sector.